Skip to main content
Article
The clinical significance of MAGEA3 expression in pancreatic cancer
International Journal of Cancer (2006)
  • Joseph Kim, Gastrointestinal Research Section, Department of Molecular Oncology, John Wayne Cancer Institute, Saint John's Health Center, Santa Monica, CA,USA
  • Howard A. Reber, University of California, Los Angeles
  • Oscar J. Hines, University of California, Los Angeles
  • Kevork K. Kazanjian, University of California, Los Angeles
  • Andy Tran, Gastrointestinal Research Section, Department of Molecular Oncology, John Wayne Cancer Institute, Saint John's Health Center, Santa Monica, CA,USA
  • Xing Ye, Division of Biostatistics, John Wayne Cancer Institute, Saint John's Health Center, Santa Monica, CA, USA
  • Farin F. Amersi, Gastrointestinal Research Section, Department of Molecular Oncology, John Wayne Cancer Institute, Saint John's Health Center, Santa Monica, CA,USA
  • Steve R. Martinez, Gastrointestinal Research Section, Department of Molecular Oncology, John Wayne Cancer Institute, Saint John's Health Center, Santa Monica, CA,USA
  • Sarah M. Dry, University of California, Los Angeles
  • Anton J. Bilchik, Division of Surgical Oncology, John Wayne Cancer Institute, Saint John's Health Center, Santa Monica, CA, USA
  • Dave S.B. Hoon
Publication Date
May 1, 2006
DOI
10.1002/ijc.21656
Citation Information
Joseph Kim, Howard A. Reber, Oscar J. Hines, Kevork K. Kazanjian, et al.. "The clinical significance of MAGEA3 expression in pancreatic cancer" International Journal of Cancer Vol. 118 Iss. 9 (2006) p. 2269 - 2275
Available at: http://works.bepress.com/dave-hoon/237/